[HTML][HTML] Understanding COVID-19-associated coagulopathy
EM Conway, N Mackman, RQ Warren… - Nature Reviews …, 2022 - nature.com
Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
COVID-19-associated coagulopathy: an exacerbated immunothrombosis response
A Jayarangaiah, PT Kariyanna… - Clinical and Applied …, 2020 - journals.sagepub.com
Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …
has posed a multitude of challenges to health care systems worldwide. In order to combat …
[HTML][HTML] Thromboplasminflammation in COVID-19 coagulopathy: three viewpoints for diagnostic and therapeutic strategies
S Gando, T Wada - Frontiers in Immunology, 2021 - frontiersin.org
Thromboplasminflammation in coronavirus disease 2019 (COVID-19) coagulopathy consists
of angiotensin II (Ang II)-induced coagulopathy, activated factor XII (FXIIa)-and kallikrein …
of angiotensin II (Ang II)-induced coagulopathy, activated factor XII (FXIIa)-and kallikrein …
[HTML][HTML] The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …
elevated D-dimer without remarkable changes of other global coagulation markers is …
Coagulation dysfunction: a hallmark in COVID-19
Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Coronavirus disease 2019–associated coagulopathy
Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
to various thrombotic complications and death. In this review, we briefly highlight possible …
Coagulopathy in COVID-19: Focus on vascular thrombotic events
W Shi, J Lv, L Lin - Journal of molecular and cellular cardiology, 2020 - Elsevier
SARS-CoV-2 causes a phenotype of pneumonia with diverse manifestation, which is termed
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …
[HTML][HTML] A review of pathophysiology, clinical features, and management options of COVID-19 associated coagulopathy
J Goswami, TA MacArthur, M Sridharan, RK Pruthi… - Shock, 2021 - journals.lww.com
There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …
COVID–19-associated coagulopathy: An exploration of mechanisms
ME Colling, Y Kanthi - Vascular Medicine, 2020 - journals.sagepub.com
An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …